Transmission of both type A and type B hepatitis to nonhuman primates is a major advance that has expedited development of tests for antibody and preparation of a type B inactivated vaccine, now under trial. The antibody tests have led to improved immune serum globulins for preventing infections. Recently a“non-A, non-B”variety has emerged as the primary cause of hepatitis in patients given multiple transfusions.